Tagged With AbbVie

Dispensed: Pharma's next big megamerger, a string of healthcare IPOs, and why the CEO of Clover Health regrets setting up shop in Silicon Valley

Allergan spikes 30% after AbbVie agrees to buy the Botox-maker for $63 billion

Abbvie is buying Allergan in a $63 billion pharma mega-deal

A cancer drug that AbbVie acquired in a $10 billion deal is looking more and more like a failure

A company that's taking a new approach to tackling Alzheimer's is moving into human trials after raising $133 million

A new treatment for a condition that can feel like tiny people skating on razor blades in your stomach and affects an estimated 200 million women just got approved

Allergan started out as a tiny but beloved Southern California eye care firm before expanding to a $130 billion company. Here's how the Botox-maker fell out grace with investors and then became a takeover target.

A company that's taking a new approach to tackling Alzheimer's just landed a $225 million endorsement

'Nobody's talking about' 2 medical conditions that affect 8 million women in America -- but that could be about to change

Here's the cancer data that led AbbVie to make the second-largest acquisition in the history of venture capital

Here's why pharma giant AbbVie coughed up $10 billion to buy a startup you've never heard of

The FDA just approved a new cancer drug -- here's what you need to know about it

Here's what the future of cancer treatment looks like

The FDA just approved an immune-system-stimulating blood cancer drug

Drugmaker AbbVie's stock gets slammed after FDA warning

Wall Street's best bankers keep leaving the industry